- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | 2026 · Mar 31, 2026 | 51.19M sh |
| Shares Diluted | 2025 · Mar 31, 2025 | 59.83M sh |
| Capex | 2026 · Mar 31, 2026 | $519K |
| Capex | 2025 · Mar 31, 2025 | $4.33M |
| Operating Cash Flow | 2026 · Mar 31, 2026 | $63.87M |
| Operating Cash Flow | 2025 · Mar 31, 2025 | $52.48M |
| Long Term Debt | 2026 · Mar 31, 2026 | $2.48B |
| Long Term Debt | 2025 · Dec 31, 2025 | $2.61B |
| Short Term Debt | 2026 · Mar 31, 2026 | $10.19M |
| Short Term Debt | 2025 · Dec 31, 2025 | $10.19M |
| Cash And Equivalents | 2026 · Mar 31, 2026 | $257.21M |
| Cash And Equivalents | 2025 · Dec 31, 2025 | $250.17M |
| Cash And Equivalents | 2025 · Mar 31, 2025 | $234.34M |
| Current Liabilities | 2026 · Mar 31, 2026 | $1.44B |
| Current Liabilities | 2025 · Dec 31, 2025 | $1.41B |
| Total Liabilities | 2026 · Mar 31, 2026 | $4.04B |
| Total Liabilities | 2025 · Dec 31, 2025 | $4.15B |
| Current Assets | 2026 · Mar 31, 2026 | $1.67B |
| Current Assets | 2025 · Dec 31, 2025 | $1.75B |
| Total Assets | 2026 · Mar 31, 2026 | $4.66B |
| Total Assets | 2025 · Dec 31, 2025 | $4.8B |
| Eps Diluted | 2026 · Mar 31, 2026 | −$0.71 |
| Eps Diluted | 2025 · Mar 31, 2025 | −$0.33 |
| Eps Basic | 2026 · Mar 31, 2026 | −$0.71 |
| Eps Basic | 2025 · Mar 31, 2025 | −$0.33 |
| Sga Expense | 2026 · Mar 31, 2026 | $168.86M |
| Sga Expense | 2025 · Mar 31, 2025 | $139.79M |
| Net Income | 2026 · Mar 31, 2026 | −$36.45M |
| Net Income | 2025 · Mar 31, 2025 | −$19.47M |
| Operating Income | 2026 · Mar 31, 2026 | $1.08M |
| Operating Income | 2025 · Mar 31, 2025 | $10.32M |
| Cost Of Revenue | 2026 · Mar 31, 2026 | $192.67M |
| Cost Of Revenue | 2025 · Mar 31, 2025 | $174.18M |
| Revenue | 2026 · Mar 31, 2026 | $442.72M |
| Revenue | 2025 · Mar 31, 2025 | $401M |